Monday, May 14, 2018

India Education Sector: Computer the Classrooms of Future India: Ken Research

Introduction: Recent market research done into the Indian Education sector has revealed that the Indian Online Learning market comprising of web based platforms, online applications and blended learning programs would be a market worth USD 2 billion. The customer base in online learning is expected to grow six fold from the current 1.6 million users to around 9.6 million by the year 2021. The increasing penetration of technology into the education market is creating a paradigm shift in the market for education in India.

Market Timeline: In 2015, the government of India launched a program to deliver free learning through online platforms; the SWAYAM initiative has been a government program to launch an online portal available to anyone wishing to learn in India with a capacity to host 2,000 courses with over 80,000 hours of video course material. The program was geared towards accessibility of quality education to rural areas aimed at connecting to 250,000 villages in India providing the population with course material from class 9 ranging to post graduate courses.  The increasing addition of participants from tier 2 and tier 3 cities like Patna and Guwahati have been noted to be the primary driver behind the growth of the market. As of July 2017, it was confirmed that the internet user base in India had reached 500 million. Educational content has been one of the most active parts of the internet with Educational related searches on Google tripling and Educational video demand doubling over the last year. Around 45% of the searches and queries are coming from beyond the top 6 metros in India. While a large number of searches and queries have resulted from schooling due to primary education still having the largest customer base of around 260 million users, the segment is poised to reach 773 million by the year 2021. The reskilling and certification segment was the most important with a value of USD 93 million expected to grow to USD 453 million by the year 2021. Competitive exams and other test preparation which is a small segment as of today is likely to grow at a CAGR of 64% to become a $515 million category in 2021. Even major corporate are taking initiatives towards reskilling with leading Indian conglomerate Mahindra and Mahindra entering into a partnership with Indian American educational tech platform edX to retrain 117,000 of its employees in various business tasks and skills . The learning platform edX alone has seen tremendous growth in the last 5-7 base owing to the addition of 1.5 million Indian customers alone which makes roughly 11% of the platforms total customer base. This shows the difference accessibility plays and even the government follows through on the trend. With access to education being the major inhibitor roughly 25% of students in India pursue higher education which is quite low compared to 70% in the US. The growing need for accessible education has been addressed in Formal education as well with the Indian government announcing in January that they will allow 15% of all Indian universities to offer online degrees for students and executives. Universities accredited by the National Assessment and Accreditation Council (NAAC) and rated A+ will be allowed to offer such courses. Others that want to offer such courses will be allowed a window of two years to achieve the A+ level in NAAC accreditation. This will not be limited to specific courses or degrees but will span a wide range of sectors and industries allowing for greater variety in the options students are allowed to remotely learn.

The emerging subjects: With Information Technology services becoming the biggest export and growing to become one of the central pillars of the Indian economy , a large number of companies and courses have opened up opportunities for entry into the IT industry within India and abroad by online learning platforms and services equipped to train students and professionals in the disciplines of Data Science, Advanced Data Analytics, Advanced Programming and in Artificial Intelligence and Machine Learning. The most promising of these opportunities being the launch of Google learning in March 2018 allowing users to enter the discipline of AI. The platform offers core AI concepts and opportunities for solving real world machine learning problems. The emergence of the online learning platform has had a major impact on the growth of online educational service firms like edX, GC Solutions, Signy, Learnnovators and more. The opportunity for greater integration and personalization of courses using AI and Machine Learning can revolutionize learning in the Indian Society

For more information, click on the link below:

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204

Premium Immunotherapies to drive HNC Therapeutics in Asia-Pacific Market: Ken Research

According  to the study “Head and Neck Cancer Therapeutics in Asia-Pacific Markets to 2023-Launch of Premium Immunotherapies and Increasing Prevalence to Drive the Market”, all the cancer therapeutic includes an array of tools at the disposal of clinicians in the treatment of cancer. However, head and neck cancer are tough situations and typically include radiotherapy, chemotherapy and surgery. These procedures are not often enough to get rid of cancer. All the cancer cells in a human body become resistant to the any type of treatments and more research is needed to overcome drug resistance. Head and neck cancer (HNC) is the sixth most common cancer, and the number of incidents is growing in Asia-Pacific region. Head and neck cancers develop inside the mouth, nose and throat. HNC is common among the ages of 55 and 64. Head and neck cancer cases are increasing drastically every year along with related deaths. It is occurring due to human papillomavirus that is increasing every year. HNC is decreasing due to smoking incidences and is most common in the middle aged population.

Every type of cancer in human body is driven by multiple, possibly dozens of somatic genetic mutations that drive cell autonomous changes in the signalling pathways. These changes ultimately influence cell growth characteristics and tumorigenicity in a human body. Cell growth indicates how a cancer cell interacts with the microenvironment, determines whether or not life-threatening metastasis is occurring and dictates the fate of cancer stem cells. In the genomics era, advancements in the medical sciences has led to the development of characterizing the genetic makeup of individual tumors, providing a potential roadmap to cancer and its treatment. All the cancer therapeutic are developed with the involvement of sophisticated molecular tools, genetically defined preclinical animal models, clinical tumor samples, and functional genomics to identify and validate either new drugs and therapeutic opportunities or to improve the outcomes of the existing therapies. Majority of the pharmaceutical companies are focusing from drug development to cancer diagnostic devices because can they help in diagnosing, monitoring, and administering drugs in the cancer treatment process. Cancer diagnostic devices help pharmaceutical companies to develop specific drugs to treat cancer. Roche’s cobas EGFR mutation test is an example to diagnoses head and neck cancers.
Various treatments in head and neck cancer involve chemotherapies, targeted therapies (anti-EGFR), and immunotherapies (PD1/PD-L1 inhibitor). In the Asia-Pacific region four targeted therapies are available for HNC such as Erbitux, BIOMAb EGFR, Opdivo, Keytruda and the rest are generics. EGFR and PD-1/PD-L1 are the most commonly used therapies in HNC along with many innovative products which reflects a deepening scientific understanding of the underlying pathophysiology of HNC. Keytruda and Opdivo are approved in many countries such as Australia, South Korea and Japan. Avelumab (a PD-L1 inhibitor) is liable to be approved in Asian-Pacific countries as it is undergoing Phase III trials in Japan, Australia and South Korea. The leading companies involved premium immunotherapies in Asia-Pacific are Biocon, Biotech Pharmaceutical Co., Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, MedImmune, Merck & Co. and Pfizer.

It was observed that there are many innovative products in the developing stage for head and neck cancer. A deep scientific understanding is required in the area of underlying pathophysiology of head and neck cancer (HNC) and the growing list of molecules that have been implicated in the initiation and progression of this disease. There are various factors contributing to the adoption, limitations, and opportunities in the head and neck cancer therapeutics in Asia-Pacific markets. The increase in aging population with increased prevalence of chronic diseases, especially in head and neck related cancers has led to the launch of premium immunotherapies in Asia-Pacific. These trends will witness a launch in the various immunotherapies across the Asia-Pacific region in the next few years.

To know more, click on the link below:
https://www.kenresearch.com/healthcare/general-healthcare/head-and-neck-cancer-therapeutics-in-asia-pacific-markets-to-2023-launch-of-premium-immunotherapies-and-increasing-prevalence-to-drive-the-market/149106-91.html

Related Reports:
https://www.kenresearch.com/healthcare/general-healthcare/cancer-pain-pipeline-review-h1/149147-91.html

https://www.kenresearch.com/healthcare/pharmaceuticals/dual-specificity-protein-kinase-ttk-cancer-testis-antigen-96-or-monopolar-spindle-1-like-1-or-phosphotyrosine-picked-threonine-protein-kinase-or-ttk-or-ec-2-7-12-1-pipeline-review-h1/149133-91.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
sales@kenresearch.com
0124-4230204

New Therapies to Bolster Asia-Pacific’s Rheumatoid Arthritis Market - Ken Research

Rheumatoid arthritis (RA) is a chronic, progressive and incurable auto-immune disease that majorly affects the joints in a human body. It is identified by synovial inflammation and gradual bone erosion over the years. The major symptoms are stiffness, pain in hands and feet and obstruct a patient’s mobility. Lack of medical help will result in joint destruction and disability. Any patient suffering from rheumatoid arthritis requires continuous treatment that is relatively very expensive. Therefore, rheumatoid arthritis therapeutic market is highly competitive due to increasing number of new drug approvals. Competition is fierce in the therapeutic market among TNF-α inhibitors for patients who are refractory to traditional disease-modifying anti-rheumatic drugs (DMARD).

Majority of the rheumatoid arthritis patients do not respond when treated with TNF-α inhibitors. Therefore, small-molecule DMARDs such as the Janus kinase (JAK) inhibitor and Xeljanz (tofacitinib) replace the ineffective TNF-α inhibitors. Xeljanz is very effective because it reduces the risk of developing cardiac diseases such as heart attack and stroke in patients. Xeljanz is an orally administered small-molecule drug which is used as a second-line treatment for rheumatoid arthritis patients who do not respond to methotrexate, and as a third-line therapy for rheumatoid arthritis patients who do not respond to biologics.

According to the study “Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023-Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs”, in Asia-Pacific region, there is a need to improve safety in the therapeutic category. Elevated rates of infection were observed due to frequent consequences of the immune-suppression involved in treatments. Therefore, biological therapies are not recommended to patients who are susceptible to any infection. There is a need to create biologics with more convenient and less invasive drug-delivery methods because the existing therapies for rheumatoid arthritis are administered subcutaneously or intravenously. Such drug delivery methods in rheumatoid arthritis patients are frequently associated with pain, rash, and allergic reactions at the injection or infusion site, in the case of infusion, flu-like illness, fever, chills, nausea, and headache. There is a need to develop convenient and safe drug administration procedures for rheumatoid arthritis patients.
Advanced medical technology has witnessed great changes in the field of diagnostic technology to strengthen the performance of rheumatoid arthritis drug manufacturers in Asia-Pacific region. The new products in the Asia-Pacific rheumatoid arthritis market are Sirukumab, an antiIL6 human mAb; Peficitinib, Upadacitinib and Filgotinib, which are JAK1 inhibitors; Olokizumab, an antiIL6 humanized IgG4 mAb; and RCT18, a recombinant human Blymphocyte stimulating factor (BLyS) receptor antibody fusion protein.

With the recently approved rheumatoid arthritis therapies along with new therapies are sure to drive the rheumatoid arthritis therapeutics market in Asia-Pacific. The promising pipeline companies are Johnson & Johnson (J&J), GlaxoSmithKline (GSK)'s sirukumab, and Galapagos's filgotinib. The leading players in rheumatoid arthritis therapeutics market are AbbVie, Amgen, Amgen, Daiichi Sankyo, Biogen Idec, Genentech, Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, Merck, Pfizer, Regeneron, Sanofi, Roche and UCB.

India, Australia, China, South Korea and Japan are the leading consumers in Asia-Pacific (APAC) rheumatoid arthritis therapeutics market. Japan accounted for a majority share of the market, followed by China, Australia, India and South Korea. The introduction of biologic disease modifying antirheumatic drugs (DMARD) has helped in the growth of the rheumatoid arthritis (RA) market in Asia-Pacific tremendously over the last two decades. This growth is expected to continue at a moderate pace in the next few years.

To know more, click on the link below:

Related Reports:


Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204

Chronic Cardiac Diseases To Drive Canada’s Prosthetic Heart Valves Market-Ken Research


According to the study “Canada Prosthetic Heart Valves Market Outlook to 2025”, the increasing incidences of chronic heart valve-related disorders such as cardio valvular diseases, valvular and heart failure, various heart disorders, arterial diseases and increase in aged population are driving the demand for cardiac prosthetic devices in Canada. Also, the rising incidence of chronic heart diseases among infants is driving the need for surgery and catheterization to correct the damaged heart valves.
Prosthetic heart valve is a device implanted in the human heart that suffers from valvular heart disease. The diseased valve is replaced with a prosthetic heart valve which results in reduction in morbidity and mortality related to cardiac valve disorders. If the heart valve disease treatment reaches an extreme point, then a surgery is recommended to repair or replace the valve. The replaced prosthetic heart valves are carbon based mechanical valves and biological tissue valves. Technological advancements, increasing rate of heart valve diseases and increasing aged population are few factors driving the growth of prosthetic heart valve market in Canada.
Prosthetic heart valves market is categorized based on products such as transcatheter heart valves, tissue heart valves, mechanical heart valves, aortic valves, mitral valves, biological heart valves, aortic valves, mitral valves, pulmonary valves, tricuspid valves, aortic valves, mitral valves and pulmonary valves. Canadian prosthetic heart valves market is moderately fragmented due to the presence of numerous large and small vendors. The leading players are Abbott Laboratories, Boston Scientific, Edwards Lifesciences, LivaNova, Lepu Medical Technology, and Medtronic.
The increasing incidences of various chronic diseases such as high blood pressure, diabetes and developed healthcare infrastructure within the country are encouraging the development and manufacture of new technological advanced prosthetic heart valve devices. The advanced design and materials are creating a positive opportunity for the adoption of prosthetic heart valve devices in the hospitals making replacement surgeries smooth due to excellent valve performance, safety, and durability. There are various opportunities in the Canadian prosthetic heart valve market due to advance surgical replacement technologies. The high cost of transcatheter aortic valve replacement devices along with stringent regulations may hamper the growth of the Canadian prosthetic heart valve market over the next few years.
To know more, click on the link below:
Related Reports:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204

India Corrugated Box Market is Driven by Rise in Demand from Fresh Food and Beverages, Logistics Application, Increasing Consumer Awareness Towards Sustainable Packaging and Growth of the E-Commerce Industry: Ken Research

Rising demand of safe and cushioned packaging of the product along with the rise in FMCG, home & personal care goods, electronic goods industries has driven the growth of corrugated boxes in the country.

Analysts at Ken Research in their latest publication India Corrugated Box Market Outlook to 2023 – by Ply/Box Type (3ply, 5ply, 7ply and 9ply), by End User (FMCG, Automotive, Textile, Electronics & Appliances and Others), by Slotted, Die-Cue Box and Others believe that promoting better regulations, procurement of automatic and updated technology machines from different countries and improved marketing strategies followed by companies will aid the corrugated box market. 
                                         
India corrugated box market is in its growth phase. Though, the craft papers prices are increasing but the demand for sustainable and safe packaging of goods is also increasing therefore new players are entering the market. Demonetization had hit the industry badly, and has also led to fall in demand for corrugated boxes as a result of slow movement of FMCG & other consumer goods from the retail counters which led to retrenchment of work force & financial losses for the industry. Despite, increase in prices of raw material in the year 2015, the production of corrugated boxes has increased at a sizeable growth rate. However, in order to increase the market growth the Indian Corrugated Case Manufacturers Association (ICCMA) and Automatic Board Plants & Western India Corrugators Box Manufacturers’ Association (WICMA) supported to grant a minimum of 12% price increase on boxes so that the Box industry is able to cover supplies of Craft Paper well in time to avoid any disruptions in the supply chain. Moreover, the industry introduced new heavyweight products such as billerud flute semi-chemical fluting. Primarily, targeted at replacing wooden packaging, this product is also able to replace double-walled board with an overall lighter weight single wall substitute.

For more information on the research report, refer to below link:
https://www.kenresearch.com/automotive-transportation-and-warehousing/logistics-and-shipping/india-corrugated-box-market/149477-100.html

Related Reports:
https://www.kenresearch.com/automotive-transportation-and-warehousing/logistics-and-shipping/us-paperboard-packaging-industry/47688-100.html
The paper board packaging market will record revenue of USD 66 Billion by 2020 due to more players entering the market, expansion of e-commerce sector in the country, increasing demand of personal care & health care products.

https://www.kenresearch.com/automotive-transportation-and-warehousing/logistics-and-shipping/india-paper-packaging-market-research-report/605-100.html
The paper packaging industry is largely comprised of unorganized players. There are a few large players such as TCPL, ITC, Parksons Packaging, and others.

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/india-recycling-pet-market-research-report/586-101.html
The future prospects of India Recycling PET Industry are impressive on the groundwork of an increase in disposable income fueled by growth in youth population that marked an increase in the availability of post consumer recycled PET waste bottles.

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249

Bio-Absorbable Stents to Encourage Growth in Brazil Peripheral Vascular Devices Market-Ken Research


According to the study “Brazil Peripheral Vascular Devices Market Outlook to 2025”, the rising prevalence of peripheral vascular disorders, diabetes and obesity in the Brazilians has led to a huge demand for stent implants. The increasing consumption of junk food and smoking has increased the risk of stroke due to formation of atherosclerotic plaques with high calcification in peripheral blood vessels. The advanced technology in stents has assisted in overcoming in-stent restenosis complications due to neointima hyperplasia and neovascularization at the site of implant. These factors are responsible for the growth in market penetration of stents utilized for treatment of peripheral vascular diseases.
Peripheral vascular disease is a condition in a human body that determines a damage or blockage in the peripheral blood vessels. It can also cause blood clots such as deep vein thrombosis, inflammation, or narrowing and blockage of the blood vessels. The various devices used for the treatment of peripheral vascular diseases are Aortic Stent Grafts, Arteriotomy Closure Devices, Carotid and Renal Artery Stents, Inferior Vena Cava Filters (IVCF), Peripheral Embolic Protection Devices, Peripheral Guidewires, Peripheral Vascular Stents, PTA Balloons Catheters, PTA Peripheral Drug Eluting Balloons (DEB) Catheters, Renal Denervation Catheters, Tip Location Devices and Vascular Grafts.
The increasing incidences of peripheral vascular disease among the Brazil population are driving the peripheral vascular devices market. The peripheral vascular devices market is highly fragmented due to multiple players. The leading players in Brazil’s peripheral vascular devices are Medtronic plc, Abbott Laboratories, Boston Scientific Corp. and others.
With the ongoing development in sophisticated healthcare infrastructure, health awareness, increase in healthcare expenditure and increasing R&D pertaining to drug discovery and development are few factors accounting for the growth in Brazil’s peripheral vascular devices market. Modernization and increasing aged population in Brazil has increased the rate of peripheral vascular diseases. In addition, the presence of untapped growth opportunities in Brazil has increased health awareness which boosted the growth in the peripheral vascular devices market. The latest market trend is the increasing use of bio-absorbable stents in the treatment of peripheral vascular disease.
To know more, click on the link below:
Related Reports
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204

Friday, May 11, 2018

UK Population Interested in Renewable Energy Compare to Nuclear Power - Ken Research

United Kingdom possesses 16 reactors that generate one sixth of the country’s power and no new nuclear plants were constructed in the recent years. The country has decided to decommission the existing nuclear fleet over the next few years as the maintenance cost is increasing drastically. UK government subsidies and support were always a part of the nuclear industry since initiation. The government provides waste disposal services for spent fuel and intermediate-level nuclear wastes. It was observed that there is an increasing construction cost of nuclear storage facilities due to many uncertainties associated with the costs of waste disposal.

The cost of clean-up from nuclear accidents is majorly covered by the government. However, the probability of any nuclear accident is very difficult to calculate because the modern reactors are often claimed to be safer than previous generation reactors. The government’s nuclear power subsidies in the United Kingdom represents an enormous opportunity cost, shaping the country’s energy system for several generations and preventing the country from investing in other renewable energy technologies. All the nuclear power plants are cost-effective, reliable, low carbon electricity system which supports the country’s needs to secure its prosperity. The leading companies in the United Kingdom’s nuclear power are NuGeneration Ltd, Horizon Nuclear Power, EDF Energy Nuclear Generation Group Limited, and China General Nuclear Power Corp.

According to the study “Nuclear Power in United Kingdom, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles”, United Kingdom may enter a new phase of nuclear power development in the next few years because nuclear energy production is expected to increase by one third more than the current production by the year 2035. UK has a total of 15 operational nuclear reactors at seven established plants with 14 advanced gas-cooled reactors, one pressurised water reactor and one nuclear reprocessing plant. Life-extensions in the advanced gas-cooled reactors are carried out to enhance more nuclear power production.

UK has announced that they would withdraw the development of new nuclear power plants in view of creating low carbon economy. The national survey on UK’s nuclear energy issues was found to be relatively low because majority of them preferred renewable energy over nuclear energy. Leukaemia and non-Hodgkin’s lymphoma cases were discovered in population residing near nuclear plants by the United Kingdom Committe on Medical Aspects of Radiation in the Environment. Therefore, there is a huge demand for wind power compared to the nuclear energy.

Earthquakes are relatively frequent in UK at a magnitude less than 6.5 but do not cause any destruction to the well-constructed nuclear structures. UK will expect extreme climatic conditions but less of tsunamis according to Energy and Climate Change Select Committee. The majority of the UK’s greenhouse gas emissions are generated from production and consumption of any source of energy such as driving cars, manufacturing goods or simply boiling a kettle. Majority of the UK population are keen to meet the carbon targets by becoming energy efficient and by switching to low-carbon fuels. More than fifty percent of the UK population are supporting nuclear power combined with renewable technologies along with energy policy and the rest of the population is expecting power from renewable resources in the next 15 years.

To know more, click on the link below:

Related Reports


Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204

Global Competitors Introducing Various Cognitive Impairment Disorder Drugs to Boost Market Growth - Ken Research

Cognitive impairment is not an illness, but a condition of the body. The patient has trouble with memory or paying attention, trouble speaking or understanding, difficulty in recognising people, places or things, and might find new places or situations overwhelming. Cognitive impairment patient is confused, agitated, or very moody. This situation can come and go which is known as delirium. The cognitive impairment disorder can be mild, or severe, or anything in between, temporary problem or a permanent condition. The major causes of temporary cognitive impairment are infections, such as a urinary tract infection or pneumonia, vitamin deficiency, dehydration, and reactions to medications. Few causes of permanent cognitive impairment are dementia, stroke and brain injury. Not every aged person will have cognitive impairment; however, cognitive impairment is more common in older people. It can be both genetic and acquired, and brain damage caused via accidents.

According to the study “Cognitive Impairment Disorders Drug Development Pipeline Review, 2018”, if left untreated, cognitive impairment disorder can worsen along with the possibility of other mental problems; therefore, various treatment options and a wide range of drugs are available. Globally, therapeutics or drugs for cognitive impairment are still under development. The key players involved in therapeutic or drug development for cognitive impairment are associated with schizophrenia (CIAS), dementia, mild cognitive impairment and Alzheimer's disease.

Drugs for cognitive impairment disorders are small molecules, due to their ability to cross the blood-brain barrier and their proven commercial success. Majority of products are neuromodulators, impacting the dopaminergic, serotonergic and glutamatergic systems. There is diversity within each drug in terms of molecule type and molecular targets. Human central nervous system (CNS) is complex and highly sophisticated in nature. Pathophysiology of cognitive impairment disorders is not well understood in the medical sciences. Therefore, treatment options are limited, and the available drugs in the market act by slowing the disease progression or treating symptoms.

The various drugs still under development for cognitive impairment disorders are above 800, respectively. The leading players in the global cognitive impairment disorders drugs development are Eli Lilly and Co., Bristol-Myers Squibb, Pfizer, AstraZeneca, AB Science SA, AbbVie Inc, Aucta Pharmaceuticals LLC, Avineuro Pharmaceuticals Inc, CereSpir Inc, CHA Bio & Diostech Co Ltd, CohBar Inc, Connexios Life Sciences Pvt Ltd, Cypralis Ltd, Daewoong Pharmaceutical Co Ltd, Daiichi Sankyo Co Ltd, Dongkook Pharmaceutical Co Ltd, Dr. August Wolff GmbH & Co KG Arzneimittel, Echo Pharmaceuticals BV, Eisai Co Ltd, Epigen Biosciences Inc, GlaxoSmithKline Plc, Golden Biotechnology Corp, Grifols SA, ID Pharma Co Ltd, Immungenetics AG, Kyowa Hakko Kirin Co Ltd, Lead Discovery Center GmbH, Merck & Co Inc, Microlin Bio Inc, ModGene Pharma LLC, Octapharma AG, Oryzon Genomics SA, Otsuka Holdings Co Ltd, Ovensa Inc, Prevacus Inc, ProMIS Neurosciences Inc, and Voyager Therapeutics Inc.

It was observed that cognitive impairment disorders will increase significantly over the next few years due to increase in aging population. Therefore, there is a strong need to develop new drugs that effectively treat symptoms and target the underlying mechanisms of disease. The advanced technology in medical sciences is encouraging cognitive impairment disorders drug development worldwide. With more players in this category, more variants of drugs are introduced for the treatment of cognitive impairment disorders. This trend will continue over the next few years due to increasing instances of cognitive impairment disorders among all age groups.

To know more, click on the link below:

Related Reports:


Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204

India Corrugated Box Market is expected to reach over INR 63,000 Crore by FY’2023: Ken Research

India corrugated box market segmentation by type of ply/box (3ply, 5ply, 7ply and 9ply), by end user (FMCG, Automotive, Textile, Electronics & Appliances and Others), by states (Gujarat, Maharashtra, Himachal, Tamil Nadu, West Bengal, UP and Others), by type of box (Slotted, Die-Cue and Others), by type of Box (Colored and Non-colored), by type of players (Organized and Un-organized) and by type of sales (Domestic and Exports), company profile of major players (Horizon Packs Pvt. Ltd, Worth Peripherals, Supack Pvt. Ltd, TGI Packaging Pvt. Ltd, Jayaraj Fortune Packaging Pvt. Ltd, OJI India Packaging Pvt. Ltd, CEL Packaging, Hariwansh Packaging, CJ Corporation, Paper Containers India, Wadpack Pvt. Ltd, Chaitanya Packaging Pvt. Ltd., BL Containers Pvt. Ltd.)

Analysts at Ken Research in their latest publication India Corrugated Box Market Outlook to 2023 – by Ply/Box Type (3ply, 5ply, 7ply and 9ply), by End User (FMCG, Automotive, Textile, Electronics & Appliances and Others), by Slotted, Die-Cue Box and Others believe that promoting better regulations, procurement of automatic and updated technology machines from different countries and improved marketing strategies followed by companies will aid the corrugated box market.

India corrugated box market is expected to register positive CAGR of around 21.8% during the period FY’2018-FY’2023. Use of corrugated for display/promotional packs, POPs and dispensers and the emergence of E-commerce industries are expected to have positive impact on the overall revenue of corrugated box market. 
  • Increasing demand from fresh food and beverages, home & personal care goods, electronic goods industries will increase the reach of end users towards corrugated box manufacturers.
  • Increasing the demand of safe and cushioned packaging of the product will augment the growth of India Corrugated box market.
  • Rise in procurement of latest technology machines from China, Taiwan and other Asian countries by manufacturers in order to make production fast and accurate will also drive the future of India corrugated box industry
The growth in use of internet for shopping, stimulated by the growing use of smart phones as well as the increasing proportion of tech-savvy consumers, has a positive effect on corrugated demand, since it has direct influence on e-commerce market. Retail ready packaging is also increasing driven by the influence of supermarkets over the retail landscape and supported by their growing share of the retail market will also drive the corrugated box market in future. Inline Automatic board and box making plants will ease out the present semi automatic production processes and deployment of folder gluers, rotary die-cutters will grow in the future. Advances in multicolor, flexo printing will facilitate in-house flexo printing, do away with screen printing and contract printing on offset presses.
The trend of colored corrugated boxes has been on the rise. Several organized retailers are using colored and die-cut corrugated boxes for display and promotional purposes in their shops. These types of boxes are mainly used in order to attract customer’s attention as these boxes are very eye catching.

Companies Covered
Horizon Packs Pvt. Ltd, Worth Peripherals Ltd., TGI Packaging Pvt. Ltd., OJI India Packaging Pvt. Ltd., Jayaraj Fortune Packaging Pvt. Ltd., Supack Industries Pvt. Ltd., BL Containers Pvt. Ltd., Chaitanya Packaging Pvt. Ltd., CEL Packaging, Wadpack Pvt. Ltd., Hariwansh Packaging Pvt. Ltd., CJ Corporation and Paper Containers India Pvt. Ltd.

For more information on the research report, refer to below link:
https://www.kenresearch.com/automotive-transportation-and-warehousing/logistics-and-shipping/india-corrugated-box-market/149477-100.html

Related Reports:
https://www.kenresearch.com/automotive-transportation-and-warehousing/logistics-and-shipping/us-paperboard-packaging-industry/47688-100.html
The paper board packaging market will record revenue of USD 66 Billion by 2020 due to more players entering the market, expansion of e-commerce sector in the country, increasing demand of personal care & health care products.

https://www.kenresearch.com/automotive-transportation-and-warehousing/logistics-and-shipping/india-paper-packaging-market-research-report/605-100.html
The paper packaging industry is largely comprised of unorganized players. There are a few large players such as TCPL, ITC, Parksons Packaging, and others.

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/india-recycling-pet-market-research-report/586-101.html
The future prospects of India Recycling PET Industry are impressive on the groundwork of an increase in disposable income fueled by growth in youth population that marked an increase in the availability of post consumer recycled PET waste bottles.

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249

Indonesia Seed Industry is dominated by PT Bisi International Tbk, PT East West Seed Indonesia, PT DuPont Indonesia, PT Syngenta Indonesia, Monsanto Indonesia and PT Advanta Seeds Indonesia : Ken Research Analysis


The agriculture sector of Indonesia has witnessed an increased demand for wide varieties of seeds. Having vast and abundant fertile soil has made Indonesia being considered amongst the major agricultural countries in the world. As per the Ministry of Agriculture, Indonesia grows 77 types of carbohydrate-rich produce, 26 types of beans, 389 types of fruits, 228 types of vegetables and 110 types of spices. An increased focus of introducing hybrid seeds by the domestic and global players in the space has significantly supported the market revenues over the recent past. Rising demand for staple food crops including rice and corn has resulted in revenues growth from the increasing sales of seeds in the market. Major crops which have supported the demand for seeds during 2016 were onions, potatoes, rice, corn, soybean, palm oil, tomatoes, chilies, green beans, cassava, sweet potato, rubber, coconut, coffee and cocoa.
Grains and cereal seeds dominated the market share to the overall revenues generated from sales of various types of seeds in Indonesia. The initiative of the government to make Indonesia a self-sufficient corn nation led to increased volumes of corn seeds being sold, thus making grains and cereals acquire a dominant position in market revenues during 2016. Indonesia is the largest palm oil producer in the world and the expansion in oil palm plantation area in the country has triggered the growth of revenues from sales of plantation crop seeds during 2016. The islands of Indonesia had about 11.3 million hectares of land under palm oil cultivation during the same year.
Rice is the staple food of Indonesia and has dominated the overall revenues generated by consumption of various types of grains and cereals seeds in the country during 2016. Indonesia has the largest per capita rice consumption in the world with Indonesians consuming around 140 kg of rice per person per year. Indonesia is amongst the top five rice producing nations in the world and produced 79.2 million tons of the final products during 2016. The surge in usage of hybrid seeds for corn production has supported the market revenues. Tempeh and tofu are major by-products of soy and provide lowest cost staple protein to the country’s population.
Indonesia has been the largest producer of palm oil in the world. The dominance of the country in global palm oil production resulted in maximum revenues being generated from sales of palm oil seeds during the same year.
Indonesia produced about 3.2 million tons of rubber during 2016 and exported majority of it to the USA, China, Japan, Singapore and Brazil. Indonesia's manufacturing industries; especially the automotive sector has been the major end user for domestically produced rubber. The country produced 350,000 tons of cocoa during 2016 and witnessed an incline in the consumption of cocoa seeds during the same year.
Prohibition on the imports of Granola potatoes, which are planted by most local farmers, surged the sale of potato seeds in the country during 2016. Rising exports of Indonesia green beans to customers in Hong Kong further boosted the production of crop in the country, thereby resulting in rising demand for green been seeds.
The rising trade of cassava for producing food items, glucose, solvents, alcohol, animal feed, fertilizers, energy and other by-products within and outside the islands of Indonesia. Of all the major fruits and vegetables grown in Indonesia, the sweet potato is a nutritious staple for the people in the Papua region. The revived cultivation of sweet potato across various regions of Indonesia resulted in offering ten varieties of the yield.
The seed market in Indonesia is highly competitive due to large number of domestic and global players offering a wide variety of seeds in the country. The market is dominated by the unorganized players which cater to the needs of the farmers to meet the growing demand for various food crops in the country. However, organized domestic and global seed market players operating in Indonesia have a dominating share merely in the sales of vegetable seeds. There are various factors on which the seed providers compete amongst each other. Some of the major factors include price of seeds, the type of seeds offered, distribution network and reach of the market players, and continuous research and development for introduction of new seeds in the country. Major organized players offering grains and cereals seeds in the country were PT Bisi International Tbk, PT DuPont Indonesia, PT Syngenta Indonesia and Monsanto Indonesia. Players which dominated the revenues from plantation crops seeds included PT SMART Tbk, PT Astra Agro Lestari Tbk, PT Eagle High Plantations Tbk and PT Sampoerna Agro Tbk. The revenues from sales of fruits and vegetables seeds were driven by PT East West Seeds Indonesia and PT Bisi International Tbk.
The demand for seeds in the country is expected to be driven primarily by the new strategic plan of the Ministry of Agriculture for 2015-2019. The emphasis on achieving self-sufficiency by increasing the production of corn, soybean, chili, onions and other major food crops during the outlook period is anticipated to boost the revenues of the players offering seeds for producing crops in Indonesia. The continuously growing population of the country is anticipated increase the demand for staple foods including rice and corn, leading to cultivation of more crops. The market is also expected to benefit from the increasing middle class population in Indonesia, which is projected to boost the demand for fruits and other horticulture crops. Indonesia seed market is anticipated to become highly competitive, with organized players gaining significant market share on the back of their strong R&D and financial strength. This is envisioned to boost the revenues of the players offering new and improved seeds in the country.
For more information on the market research report please refer to the below link:
Related Reports:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204